Table 3. Lipinski and Veber rules of selected aza compounds (1-6).
| Compound | MW | iLogP | HBD (nOHNH) | HBA (nON) | nrotb | MR | TPSA | Lipinski #violations | Bio availability score |
| Lipinski* | ≤500 | ≤5 | ≤5 | ≤10 | ≤10 | - | - | ||
| Veber** | - | - | - | - | - | - | ≤ 140 | ||
| 1 | 430.52 | 3 | 3 | 6 | 5 | 124.02 | 133.27 | 0 | 0.55 |
| 2 | 446.52 | 2.95 | 3 | 7 | 6 | 124.65 | 125.52 | 0 | 0.55 |
| 3 | 474.57 | 3.6 | 3 | 7 | 8 | 134.26 | 125.52 | 0 | 0.55 |
| 4 | 488.6 | 3.35 | 2 | 7 | 8 | 139.16 | 116.73 | 0 | 0.55 |
| 5 | 448.49 | 2.82 | 4 | 8 | 5 | 121.77 | 159.74 | 0 | 0.55 |
| 6 | 488.6 | 3.35 | 3 | 7 | 9 | 139.07 | 125.52 | 0 | 0.55 |
| Amoxicillin | 365.4 | 1.46 | 4 | 6 | 5 | 94.59 | 158.26 | 0 | 0.55 |
| Moxifloxacin | 401.43 | 2.78 | 2 | 6 | 4 | 114.05 | 83.8 | 0 | 0.55 |
| Sulfanilamide | 172.2 | 0.61 | 2 | 3 | 1 | 41.84 | 94.56 | 0 | 0.55 |
| Sulfamethoxazole | 253.28 | 1.03 | 2 | 4 | 3 | 62.99 | 106.6 | 0 | 0.55 |